| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.753 | 0.003 | 0.753 | Anesthetic general | |||
| 0.571 | 0.002 | 0.571 | Lipocortins synthesis antagonist | 0.313 0.019 CID_154699745 | ||
| 0.489 | 0.012 | 0.489 | Psychostimulant | 0.24 0.062 CID_154699745 | ||
| 0.48 | 0.014 | 0.48 | Anticonvulsant | |||
| 0.46 | 0.009 | 0.46 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.447 | 0.04 | 0.447 | Aldehyde oxidase inhibitor | |||
| 0.386 | 0.052 | 0.386 | Cholesterol antagonist | |||
| 0.332 | 0.026 | 0.332 | RNA-directed DNA polymerase inhibitor | |||
| 0.314 | 0.02 | 0.314 | Diuretic | 0.131 0.094 CID_154699745 | ||
| 0.401 | 0.11 | 0.401 | Caspase 9 stimulant | |||
| 0.367 | 0.078 | 0.367 | Immunosuppressant | 0.205 0.192 CID_154699745 | ||
| 0.286 | 0.021 | 0.286 | Tumour necrosis factor antagonist | |||
| 0.32 | 0.057 | 0.32 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.286 | 0.028 | 0.286 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.319 | 0.063 | 0.319 | Spasmolytic | |||
| 0.318 | 0.064 | 0.403 | Sodium/bile acid cotransporter inhibitor | 0.403 0.016 CID_154699745 | CID_154699745 | |
| 0.314 | 0.064 | 0.336 | Interleukin 2 agonist | 0.336 0.052 CID_154699745 | CID_154699745 | |
| 0.25 | 0.008 | 0.25 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.278 | 0.058 | 0.369 | Angiogenesis stimulant | 0.369 0.028 CID_154699745 | CID_154699745 | |
| 0.295 | 0.097 | 0.349 | Transcription factor NF kappa B inhibitor | 0.349 0.077 CID_154699745 | CID_154699745 | |
| 0.261 | 0.07 | 0.261 | Tumour necrosis factor alpha release inhibitor | |||
| 0.201 | 0.025 | 0.201 | Adenylate cyclase inhibitor | |||
| 0.206 | 0.039 | 0.206 | NOS3 expression enhancer | |||
| 0.238 | 0.075 | 0.238 | DNA synthesis inhibitor | |||
| 0.197 | 0.036 | 0.197 | Arachidonic acid antagonist | |||
| 0.179 | 0.022 | 0.179 | Bronchodilator | |||
| 0.16 | 0.006 | 0.16 | Phosphodiesterase 4C inhibitor | |||
| 0.164 | 0.012 | 0.164 | Anabolic | 0.096 0.069 CID_154699745 | ||
| 0.174 | 0.025 | 0.174 | Nav1.1 sodium channel blocker | |||
| 0.141 | 0.008 | 0.141 | Androgen agonist | |||
| 0.16 | 0.028 | 0.16 | Interleukin 8 antagonist | |||
| 0.225 | 0.11 | 0.225 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.171 | 0.056 | 0.171 | Interferon gamma antagonist | |||
| 0.139 | 0.026 | 0.139 | Androgen antagonist | |||
| 0.131 | 0.024 | 0.131 | Phosphodiesterase 4D inhibitor | |||
| 0.111 | 0.004 | 0.111 | Glucocorticoid antagonist | |||
| 0.254 | 0.151 | 0.254 | GABA C receptor rho-3 antagonist | |||
| 0.208 | 0.115 | 0.547 | Immunostimulant | 0.547 0.023 CID_154699745 | CID_154699745 | |
| 0.098 | 0.006 | 0.098 | RNA-directed RNA polymerase stimulant | |||
| 0.112 | 0.023 | 0.112 | Glycine receptor antagonist | |||
| 0.245 | 0.159 | 0.245 | Histamine release inhibitor | |||
| 0.091 | 0.008 | 0.091 | Lipocortins synthesis agonist | |||
| 0.112 | 0.03 | 0.112 | Interleukin 5 antagonist | |||
| 0.145 | 0.063 | 0.145 | Pregnane X receptor agonist | |||
| 0.089 | 0.009 | 0.089 | Mineralocorticoid receptor antagonist | |||
| 0.12 | 0.044 | 0.12 | UDP-glucose 4-epimerase inhibitor | |||
| 0.172 | 0.102 | 0.172 | MAP kinase kinase 2 inhibitor | |||
| 0.077 | 0.008 | 0.077 | Pregnane X receptor antagonist | |||
| 0.206 | 0.14 | 0.233 | Gastrin inhibitor | 0.233 0.101 CID_154699745 | CID_154699745 | |
| 0.074 | 0.013 | 0.074 | 5-Alpha-reductase inhibitor | |||
| 0.071 | 0.014 | 0.071 | Aldosterone antagonist | |||
| 0.133 | 0.081 | 0.133 | Lipid peroxidase inhibitor | |||
| 0.058 | 0.007 | 0.058 | 5-Alpha-reductase 1 inhibitor | |||
| 0.189 | 0.143 | 0.189 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.05 | 0.007 | 0.05 | 5-Alpha-reductase 2 inhibitor | |||
| 0.046 | 0.005 | 0.046 | Progesterone agonist | |||
| 0.142 | 0.102 | 0.142 | Interleukin 6 antagonist | |||
| 0.054 | 0.017 | 0.054 | Progesterone antagonist | |||
| 0.112 | 0.075 | 0.112 | DNA polymerase I inhibitor | |||
| 0.053 | 0.016 | 0.053 | Phosphodiesterase 6C inhibitor | |||
| 0.206 | 0.169 | 0.206 | Vasodilator, peripheral | |||
| 0.07 | 0.034 | 0.07 | Aromatase inhibitor | |||
| 0.04 | 0.011 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.094 | 0.065 | 0.094 | Phosphodiesterase 6D inhibitor | |||
| 0.078 | 0.052 | 0.078 | Na+ K+ transporting ATPase inhibitor | |||
| 0.24 | 0.217 | 0.24 | Calcium channel L-type activator | |||
| 0.067 | 0.045 | 0.067 | Phosphodiesterase III inhibitor | |||
| 0.029 | 0.007 | 0.029 | Corticosteroid-like | |||
| 0.033 | 0.011 | 0.033 | DNA polymerase III inhibitor | |||
| 0.041 | 0.02 | 0.041 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.128 | 0.107 | 0.128 | Adenylate cyclase stimulant | |||
| 0.03 | 0.01 | 0.03 | Estrone sulfatase inhibitor | |||
| 0.111 | 0.092 | 0.111 | DNA repair enzyme inhibitor | |||
| 0.052 | 0.034 | 0.052 | Phosphodiesterase 4A inhibitor | |||
| 0.132 | 0.113 | 0.132 | Heat shock protein 70 antagonist | |||
| 0.102 | 0.084 | 0.102 | Acetylcholine release stimulant | |||
| 0.075 | 0.057 | 0.075 | Keratolytic | |||
| 0.061 | 0.043 | 0.061 | Heme oxygenase stimulant | |||
| 0.043 | 0.025 | 0.043 | Thymidine kinase inhibitor | |||
| 0.076 | 0.059 | 0.076 | Acetylcholine nicotinic antagonist | |||
| 0.169 | 0.153 | 0.169 | Cardiotonic | |||
| 0.094 | 0.078 | 0.094 | AMP-activated protein kinase stimulant | |||
| 0.12 | 0.105 | 0.12 | Farnesoid X receptor antagonist | |||
| 0.032 | 0.018 | 0.032 | Phosphodiesterase 6B inhibitor | |||
| 0.1 | 0.088 | 0.1 | Alkylator | |||
| 0.016 | 0.004 | 0.016 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.103 | 0.091 | 0.103 | Estrogen antagonist | |||
| 0.019 | 0.008 | 0.019 | Glucocorticoid agonist | |||
| 0.034 | 0.023 | 0.034 | Purinergic P2Y2 antagonist | |||
| 0.021 | 0.011 | 0.021 | Progesterone receptor B antagonist | |||
| 0.024 | 0.015 | 0.024 | Phosphodiesterase 6H inhibitor | |||
| 0.024 | 0.015 | 0.024 | Phosphodiesterase 6G inhibitor | |||
| 0.016 | 0.008 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.167 | 0.159 | 0.178 | Superoxide dismutase inhibitor | 0.178 0.144 CID_154699745 | CID_154699745 | |
| 0.057 | 0.049 | 0.057 | Ryanodine receptor antagonist | |||
| 0.068 | 0.06 | 0.068 | Glycine receptor agonist | |||
| 0.085 | 0.077 | 0.085 | DNA directed RNA polymerase inhibitor | |||
| 0.111 | 0.103 | 0.111 | Protein kinase stimulant | |||
| 0.087 | 0.081 | 0.087 | Bile acid receptor antagonist | |||
| 0.13 | 0.123 | 0.13 | Antipruritic | |||
| 0.092 | 0.086 | 0.092 | Cystathionine beta-synthase inhibitor | |||
| 0.106 | 0.102 | 0.106 | Nav1.2 sodium channel blocker | |||
| 0.025 | 0.024 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.024 | 0.075 | 0.038 | Membrane dipeptidase inhibitor | 0.038 0.029 CID_154699745 | CID_154699745 | |
| 0.037 | 0.093 | 0.083 | Matrix metalloproteinase inhibitor | 0.083 0.035 CID_154699745 | CID_154699745 | |
| 0.094 | 0.182 | 0.28 | Growth hormone agonist | 0.28 0.036 CID_154699745 | CID_154699745 | |
| 0.138 | 0.233 | 0.266 | Peptidyltransferase inhibitor | 0.266 0.04 CID_154699745 | CID_154699745 | |
| 0.063 | 0.167 | 0.131 | Mucolytic | 0.131 0.045 CID_154699745 | CID_154699745 | |
| 0.041 | 0.147 | 0.08 | Metalloproteinase-2 inhibitor | 0.08 0.052 CID_154699745 | CID_154699745 | |
| 0.05 | 0.165 | 0.115 | Expectorant | 0.115 0.055 CID_154699745 | CID_154699745 | |
| 0.09 | 0.214 | 0.21 | Hepatoprotectant | 0.21 0.059 CID_154699745 | CID_154699745 | |
| 0.035 | 0.188 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_154699745 | CID_154699745 | |
| 0.131 | 0.323 | 0.236 | Apoptosis antagonist | 0.236 0.141 CID_154699745 | CID_154699745 | |
| 0.064 | 0.268 | 0.131 | Factor V inhibitor | 0.131 0.029 CID_154699745 | CID_154699745 | |
| 0.01 | 0.239 | 0.048 | Toll-Like receptor 2 agonist | 0.048 0.024 CID_154699745 | CID_154699745 | |
| 0.02 | 0.251 | 0.118 | Glutamate decarboxylase inhibitor | 0.118 0.021 CID_154699745 | CID_154699745 | |
| 0.023 | 0.264 | 0.071 | Sirtuin 1 inhibitor | 0.071 0.043 CID_154699745 | CID_154699745 | |
| 0.07 | 0.332 | 0.275 | Vasodilator | 0.275 0.057 CID_154699745 | CID_154699745 | |
| 0.016 | 0.291 | 0.068 | Histidine decarboxylase inhibitor | 0.068 0.053 CID_154699745 | CID_154699745 | |
| 0.099 | 0.4 | 0.244 | Antibacterial | 0.244 0.182 CID_154699745 | CID_154699745 | |
| 0.045 | 0.365 | 0.399 | Interleukin antagonist | 0.399 0.031 CID_154699745 | CID_154699745 | |
| 0.03 | 0.357 | 0.228 | Thrombolytic | 0.228 0.04 CID_154699745 | CID_154699745 | |
| 0.065 | 0.392 | 0.142 | Phospholipase C inhibitor | 0.142 0.123 CID_154699745 | CID_154699745 | |
| 0.04 | 0.374 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.071 CID_154699745 | CID_154699745 | |
| 0.044 | 0.396 | 0.153 | Histone deacetylase SIRT1 inhibitor | 0.153 0.059 CID_154699745 | CID_154699745 | |
| 0.005 | 0.357 | 0.114 | Kinesin antagonist | 0.114 0.006 CID_154699745 | CID_154699745 | |
| 0.005 | 0.357 | 0.114 | Kinesin-like protein 1 inhibitor | 0.114 0.006 CID_154699745 | CID_154699745 | |
| 0.042 | 0.408 | 0.114 | Hematopoietic | 0.114 0.025 CID_154699745 | CID_154699745 | |
| 0.022 | 0.404 | 0.175 | Aminopeptidase B inhibitor | 0.175 0.028 CID_154699745 | CID_154699745 | |
| 0.02 | 0.475 | 0.103 | Chelator | 0.103 0.073 CID_154699745 | CID_154699745 | |
| 0.018 | 0.52 | 0.128 | Glutathione S-transferase inhibitor | 0.128 0.019 CID_154699745 | CID_154699745 | |
| 0.005 | 0.535 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.036 CID_154699745 | CID_154699745 | |
| 0.01 | 0.668 | 0.105 | Protease inhibitor | 0.105 0.061 CID_154699745 | CID_154699745 | |
| 0.007 | 0.712 | 0.036 | Erythropoietin receptor agonist | 0.036 0.032 CID_154699745 | CID_154699745 | |
| 0.008 | 0.748 | 0.204 | Anticoagulant | 0.204 0.052 CID_154699745 | CID_154699745 | |
| 0.003 | 0.958 | 0.065 | Glucagon-like peptide 1 agonist | 0.065 0.045 CID_154699745 | CID_154699745 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |